Home2IVB • FRA
add
Indivior PLC
Previous close
€8.95
Day range
€8.90 - €8.90
Year range
€6.80 - €20.00
Market cap
936.36M GBP
Avg Volume
34.00
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 299.00M | 2.05% |
Operating expense | 212.00M | 1.92% |
Net income | 59.00M | 176.62% |
Net profit margin | 19.73 | 175.08% |
Earnings per share | 0.32 | -25.84% |
EBITDA | 62.00M | 19.23% |
Effective tax rate | 32.18% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 320.00M | -21.95% |
Total assets | 1.32B | -25.06% |
Total liabilities | 1.67B | -14.56% |
Total equity | -348.00M | — |
Shares outstanding | 124.66M | — |
Price to book | -3.22 | — |
Return on assets | 9.70% | — |
Return on capital | 187.50% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 59.00M | 176.62% |
Cash from operations | -5.00M | 98.12% |
Cash from investing | 10.00M | 11.11% |
Cash from financing | 27.00M | 169.23% |
Net change in cash | 31.00M | 110.54% |
Free cash flow | -56.88M | 81.24% |
About
Indivior is a specialty pharmaceuticals business. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, the company has been fined for false marketing claims about the safety of its drug, Suboxone. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market. Wikipedia
Founded
Sep 26, 2014
Website
Employees
1,041
